We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FVCB:NASDAQFVCBankcorp, Inc. Analysis

Data as of 2026-07-19 - not real-time

$17.82

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

FVCBankcorp is trading in the mid‑$teens with a bullish technical set‑up: the 20‑day SMA (≈$17.4) sits above the 50‑day SMA (≈$16.5) and both are above the 200‑day SMA (≈$14.7), confirming an uptrend. The RSI is at 61, indicating momentum without overbought pressure, while the MACD line has crossed above its signal line, generating a bullish histogram. Price is holding just above the identified support around $16.42 and below the resistance near $18.36, suggesting limited downside and a modest upside target. Fundamentally, the stock trades at a forward PE of 11.2 versus an industry average of 17.8, and the DCF model values the company at roughly $35, implying a substantial undervaluation gap. Revenue growth of 16‑17% and an operating margin near 47% underscore strong earnings power, while a low payout ratio (≈14%) and a newly declared $0.07 dividend point to sustainable income. The balance sheet is solid with ample cash, modest debt, and a beta of 0.5, indicating lower market sensitivity. Overall, the combination of bullish technicals, attractive valuation, and steady dividend makes FVCB a compelling candidate for investors seeking growth‑oriented value in the regional banking sector.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical alignment (SMA hierarchy, MACD crossover)
  • Support level intact and volume trend still supportive
  • Recent dividend declaration adds immediate yield

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation gap suggests modest upside but price near resistance
  • Sustained earnings growth and strong operating margins
  • Regional bank sector exposure to credit cycles

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates significant upside over current price
  • Low beta and solid balance sheet reduce systematic risk
  • Stable dividend with low payout ratio supports total return

Key Metrics & Analysis

Financial Health

Revenue Growth16.70%
Profit Margin34.03%
P/E Ratio13.9
ROE9.26%
ROA1.02%
P/B Ratio1.2
Op. Cash Flow$26.1M
Industry P/E17.8

Technical Analysis

TrendBullish
RSI61.1
Support$16.42
Resistance$18.36
MA 20$17.42
MA 50$16.53
MA 200$14.74
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value$35.25
Target Price$18.38
Upside/Downside3.11%
GradeUndervalued
TypeGrowth
Dividend Yield1.57%

Risk Assessment

Beta0.50
Volatility21.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.